Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Halopemide is a potent inhibitor of PLD (IC50 = 220 and 310 nM for human PLD1 and PLD2). Halopemid is an antagonist of dopamine receptors. Halopemid can be used in psychotropic research.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 11,500 | |||
5 mg | 在庫あり | ¥ 29,500 | |||
10 mg | 在庫あり | ¥ 49,000 | |||
25 mg | 在庫あり | ¥ 98,500 | |||
50 mg | 在庫あり | ¥ 147,000 | |||
100 mg | 在庫あり | ¥ 204,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 33,000 |
説明 | Halopemide is a potent inhibitor of PLD (IC50 = 220 and 310 nM for human PLD1 and PLD2). Halopemid is an antagonist of dopamine receptors. Halopemid can be used in psychotropic research. |
ターゲット&IC50 | PLD1:220 nM, PLD2:310 nM |
分子量 | 416.88 |
分子式 | C21H22ClFN4O2 |
CAS No. | 59831-65-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (131.93 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Halopemide 59831-65-1 GPCR/G Protein Metabolism Neuroscience Others Dopamine Receptor Phospholipase inhibit psychotropic calcification MOVAS Inhibitor cells dyskinesias cancer inhibitor